Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 12 2016 000 105.2 |
| Use | VZ | Medicinal products |
| 95 | Product name | TIEZ | CEFTAZIDIM ODER EIN SALZ DAVON MIT AVIBACTAM ODER EIN SALZ DAVON |
| 54 | Title of basic patent | TIGZ | HETEROCYCLISCHE VERBINDUNGEN DIE ALS BETA-LACTAMASEHEMMER AKTIV SIND |
| 51 | IPC main class | ICM (ICMV) | A61K 31/439 (2006.01) |
| 51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/4995 (2006.01), A61K 31/55 (2006.01), A61K 31/553 (2006.01), A61P 31/04 (2006.01) |
| 94 | Start of term of protection | LB | Jan 28, 2023 |
| 94 | End of term of protection | LE | Jul 27, 2028 |
| 22 | DE application date | DAT | Dec 14, 2016 |
| Date of publication of application for a certificate | OT | Feb 16, 2017 |
| Date of publication of grant of certificate | PET | Jan 14, 2021 |
| 71/73 | Applicant/owner | INH | Pfizer Ireland Pharmaceuticals Unlimited Company, P43 X336 Ringaskiddy, Cork, IE |
| 74 | Representative | VTR | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Due date | FT FG | Jan 31, 2026 Annual fee for the 24th year
Patent fees |
| Patent division in charge | | 44 |
| 68 | DE file number of basic patent | GAKZ | 603 34 527.1 |
| 68 | EP file number of basic patent | GEAKZ | 03 70 9903.3 |
| 43 | Date of first publication | EVT | Feb 16, 2017 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/16/1109 2016-06-24
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/16/1109 2016-06-24
|
| Date of the first transfer into DPMAregister | EREGT | Feb 16, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 28, 2025 (Show all update days)(Hide all update days)- Nov 28, 2025
- End of term of protection: changed
- Procedures: Supplementary protection certificate procedure, Decision on grant of application for extended duration has become final, 21.10.2025: new
- Sep 16, 2025
- Procedures: Supplementary protection certificate procedure, Protection certificate - grant application extension duration, 15.09.2025: new
- Sep 13, 2025
- St.36: changed (technical change)
- Aug 29, 2025
- Procedures: Supplementary protection certificate procedure, Application for extended duration of certificate, 05.08.2025: new
- Jul 12, 2025
- Applicant/owner: changed
- Procedures: New applicant/owner details, New applicant/owner details, 11.07.2025: new
- Jun 6, 2025
- St.36: changed (technical change)
- Jan 15, 2025
- Nov 12, 2024
- Representative: changed
- Procedures: New representative details, New representative details, 14.11.2017: changed
- Procedures: New representative details, New representative details, 17.06.2020: changed
- Aug 13, 2024
- St.36: changed (technical change)
- Jan 10, 2024; Jan 5, 2023; Jan 22, 2021; Jan 15, 2021; Dec 5, 2020; Sep 29, 2020; Jun 18, 2020; Aug 30, 2019; Jul 16, 2019; Nov 15, 2017
- Historical data not available for this/these date(s)
- Feb 16, 2017
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)| INID | Criterion | Field | Content
Close details
|
|---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 11, 2025 |
| 71/73 | Applicant/owner | INH | Pfizer Ireland Pharmaceuticals Unlimited Company, P43 X336 Ringaskiddy, Cork, IE |
| 71/73 | Previous applicant/owner | INHF | Pfizer Ireland Pharmaceuticals (a private unlimited liability company incorporated in Ireland), Ringaskiddy, Co Cork, IE |
| Date of update of the procedure | REGT | Jul 12, 2025 |